SCHEMBL30973587

SCHEMBL30973587

CCC1CC(=O)c2ccoc2C1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 7/20 0.52
HTR2A P28223 5/20 0.46
DRD2 P14416 4/20 0.45
LMNA P02545 3/20 0.41
MAPT P10636 3/20 0.41
POLB P06746 3/20 0.41
ALDH1A1 P00352 3/20 0.41
HTT P42858 2/20 0.41
MEN1 O00255 1/20 0.41
RECQL P46063 1/20 0.41
KMT2A Q03164 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
GRM5 P41594 1/20 0.36
HSD17B10 Q99714 2/20 0.31
GAA P10253 1/20 0.31
HSP90AA1 P07900 1/20 0.31
RAB9A P51151 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
KDM4E B2RXH2 1/20 0.30
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22905751 0.77 HTR2C (0.43) HTR2CHTR2ADRD2LMNAMAPT
SCHEMBL22905577 0.72 HTR2C (0.40) HTR2CHTR2ADRD2POLBHSD17B10
SCHEMBL30973541 0.68 HTR2C (0.34) HTR2CHTR2ADRD2POLBHSD17B10
SCHEMBL6101336 0.68 HSD17B10 (0.49) HTR2CHTR2ADRD2MAPTPOLB
SCHEMBL13677130 0.67 ACHE (0.46) HTR2CPOLBHSD17B10GAAKDM4E
SCHEMBL16663984 0.67 HTR2C (0.48) HTR2CDRD2LMNAMAPTPOLB
SCHEMBL6024691 0.64 BUB1 (0.38) LMNAMAPTPOLBALDH1A1HTT
SCHEMBL2840999 0.63 KMT2A (0.43) HTR2ALMNAMAPTPOLBALDH1A1
SCHEMBL3129135 0.62 HSD17B10 (0.39) HTR2CMAPTPOLBALDH1A1MEN1
SCHEMBL333300 0.62 MAPT (0.42) HTR2CMAPTPOLBALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4642784-A1 HETEROCYCLIC AND HETEROARYL COMPOUNDS AS INHIBITORS OF NLRP3 PTC Therapeutics, Inc. (US) 2025-11-05 EP disclosed
WO-2024145623-A1 HETEROCYCLIC AND HETEROARYL COMPOUNDS AS INHIBITORS OF NLRP3 PTC THERAPEUTICS, INC. (US) 2024-07-04 WO disclosed